Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Intra-Cellular Therapies, Inc.
About ITCI
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate. Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity.
Find out what a historical investment in Intra-Cellular Therapies, Inc. would be worth today using our ITCI stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy ITCI shares in Australia?
Buying ITCI shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Intra-Cellular Therapies, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ITCI
What is the ticker symbol of Intra-Cellular Therapies, Inc.?
The ticker symbol for Intra-Cellular Therapies, Inc. is ITCI.
How much is one share of ITCI?
One share of ITCI is valued at $131.87 as of 16 May 2026.
What is the market capitalisation of Intra-Cellular Therapies, Inc. ITCI?
As of 16 May 2026 Intra-Cellular Therapies, Inc. has a market cap of -.
What is the 52-week high for Intra-Cellular Therapies, Inc. stock?
The Intra-Cellular Therapies, Inc. 52-week high stock price is $NaN.
What is the 52-week low for Intra-Cellular Therapies, Inc. stock?
The Intra-Cellular Therapies, Inc. 52-week low stock price is $NaN.
Can I buy ITCI shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ITCI shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ITCI on Stake
- Buy ITCI from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ITCI from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ITCI related stocks